Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Headache. 2010 Jan 20;50(6):1031–1040. doi: 10.1111/j.1526-4610.2009.01609.x

Table 3.

Multivariable-adjusted* hazard ratios (HRs) and 95% confidence intervals (CIs) for ischemic vascular events among women with active migraine according to migraine features in the Women’s Health Study (N=27,840)

No migraine history (N=22,715) Active migraine with aura (N=1,434) P value Active migraine without aura (N=2,176) P value Prior migraine (N=1,515) P value

Major Cardiovascular Event N=567 N=54 N=39 N=48

 Overall 1.00 2.01 (1.52–2.67) <0.0001 1.04 (0.75–1.44) 0.81 1.13 (0.84–1.52) 0.41

 Attack duration of 4–72 hours
  Yes ——— 2.11 (1.53–2.89) <0.0001 0.98 (0.67–1.44) 0.93 ———
  No 1.74 (0.98–3.09) 0.06 1.22 (0.67–2.22) 0.51

 Unilateral pain location
  Yes ——— 2.05 (1.43–2.96) 0.0001 0.87 (0.54–1.40) 0.57 ———
  No 1.96 (1.29–2.97) 0.002 1.24 (0.80–1.93) 0.33

 Photophobia
  Yes ——— 1.87 (1.33–2.61) 0.0003 1.00 (0.66–1.51) 0.99 ———
  No 2.42 (1.49–3.93) 0.0003 1.11 (0.67–1.87) 0.68

 Phonophobia
  Yes ——— 1.85 (1.19–2.86) 0.006 0.85 (0.50–1.46) 0.56 ———
  No 2.13 (1.50–3.04) <0.0001 1.18 (0.79–1.77) 0.41

 Nausea/vomiting
  Yes ——— 1.64 (1.12–2.40) 0.01 1.00 (0.66–1.51) 0.99 ———
  No 2.66 (1.79–3.94) <0.0001 1.11 (0.66–1.85) 0.70

 Pulsating pain quality
  Yes ——— 1.93 (1.30–2.86) 0.001 0.58 (0.32–1.02) 0.06 ———
  No 2.09 (1.43–3.07) 0.0002 1.62 (1.10–2.38) 0.02

 Aggravation by physical activity
  Yes ——— 1.73 (1.01–2.95) 0.04 0.78 (0.42–1.46) 0.43 ———
  No 2.13 (1.54–2.95) <0.0001 1.18 (0.81–1.71) 0.40

Ischemic stroke N=257 N=22 N=17 N=16

 Overall 1.00 1.79 (1.15–2.78) 0.01 1.01 (0.61–1.65) 0.98 0.82 (0.50–1.36) 0.45

 Attack duration of 4–72 hours
  Yes ——— 1.64 (0.97–2.77) 0.06 1.17 (0.69–1.97) 0.57 ———
  No 2.22 (1.05–4.72) 0.04 0.50 (0.12–2.00) 0.33

 Unilateral pain location
  Yes ——— 1.42 (0.75–2.68) 0.28 0.75 (0.35–1.59) 0.45 ———
  No 2.28 (1.28–4.08) 0.006 1.32 (0.70–2.49) 0.39

 Photophobia
  Yes ——— 1.43 (0.82–2.51) 0.21 1.12 (0.62–2.00) 0.71 ———
  No 2.80 (1.44–5.46) 0.003 0.81 (0.33–1.97) 0.64

 Phonophobia
  Yes ——— 1.34 (0.63–2.85) 0.44 0.55 (0.20–1.48) 0.24 ———
  No 2.12 (1.25–3.58) 0.005 1.35 (0.77–2.36) 0.30

 Nausea/vomiting
  Yes ——— 0.91 (0.43–1.93) 0.80 1.20 (0.68–2.11) 0.52 ———
  No 3.27 (1.93–5.51) <0.0001 0.66 (0.25–1.77) 0.41

 Pulsating pain quality
  Yes ——— 1.66 (0.88–3.13) 0.12 0.85 (0.42–1.73) 0.66 ———
  No 1.92 (1.07–3.43) 0.03 1.20 (0.61–2.34) 0.60

 Aggravation by physical activity
  Yes ——— 1.61 (0.71–3.62) 0.25 1.05 (0.46–2.36) 0.91 ———
  No 1.87 (1.13–3.11) 0.02 0.98 (0.54–1.81) 0.96

Myocardial infarction N=243 N=25 N=17 N=20

 Overall 1.00 2.11 (1.39–3.21) 0.0004 1.01 (0.62–1.66) 0.96 1.08 (0.68–1.70) 0.74

 Attack duration of 4–72 hours
  Yes ——— 2.26 (1.42–3.59) 0.0006 0.86 (0.47–1.57) 0.62 ———
  No 1.68 (0.69–4.08) 0.25 1.51 (0.67–3.41) 0.32

 Unilateral pain location
  Yes ——— 2.26 (1.34–3.83) 0.002 0.97 (0.50–1.90) 0.93 ———
  No 1.93 (1.02–3.64) 0.04 1.06 (0.53–2.16) 0.86

 Photophobia
  Yes ——— 2.39 (1.52–3.76) 0.0002 1.00 (0.55–1.84) 0.99 ———
  No 1.32 (0.49–3.56) 0.58 1.03 (0.46–2.33) 0.94

 Phonophobia
  Yes ——— 2.14 (1.16–3.93) 0.01 1.07 (0.52–2.16) 0.86 ———
  No 2.10 (1.22–3.61) 0.008 0.97 (0.50–1.89) 0.92

 Nausea/vomiting
  Yes ——— 1.98 (1.17–3.36) 0.01 1.02 (0.55–1.87) 0.95 ———
  No 2.35 (1.24–4.43) 0.009 1.00 (0.44–2.25) 0.99

 Pulsating pain quality
  Yes ——— 1.81 (0.98–3.32) 0.06 0.32 (0.10–1.00) 0.05 ———
  No 2.43 (1.41–4.18) 0.001 1.88 (1.09–3.23) 0.02

 Aggravation by physical activity
  Yes ——— 1.40 (0.58–3.42) 0.46 0.51 (0.16–1.60) 0.25 ———
  No 2.42 (1.53–3.83) 0.0002 1.28 (0.74–2.20) 0.38
*

controlling for: age, body mass index, diabetes, physical activity, postmenopausal hormone use, oral contraceptive use, history of hypertension, alcohol consumption, smoking, family history of premature myocardial infarction, LDL levels, HDL levels.

A major cardiovascular event was defined as the first of any of these events: nonfatal ischemic stroke, nonfatal myocardial infarction, or death from ischemic cardiovascular cause.